Back
Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
APLS
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
33
APLS
Apellis Pharmaceuticals
Last Price:
26.19
Seasonality Move:
20.78%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Apellis Pharmaceuticals Price Quote
$26.19
-0.08 (-0.3%)
(Updated: November 18, 2024 at 5:55 PM ET)
Apellis Pharmaceuticals Key Stats
Sell
33
Apellis Pharmaceuticals (APLS)
is a Sell
Day range:
$26.02 - $28.05
52-week range:
$24.34 - $73.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.52
P/B ratio:
13.78%
Volume:
5.5M
Avg. volume:
3.2M
1-year change:
-45.72%
Market cap:
$3.3B
Revenue:
$396.6M
EPS:
$-2.03
How Much Does Apellis Pharmaceuticals Make?
-
How Much Are Apellis Pharmaceuticals's Sales Annually?
APLS Revenues are $396.6M -
How Much Profit Does Apellis Pharmaceuticals's Make A Year?
APLS net income is -$528.6M
Is Apellis Pharmaceuticals Growing As A Company?
-
What Is Apellis Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.78% -
What Is Apellis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Apellis Pharmaceuticals Stock Price Performance
-
Did Apellis Pharmaceuticals Stock Go Up Last Month?
Apellis Pharmaceuticals share price went down by -6.01% last month -
Did APLS's Share Price Rise Over The Last Year?
APLS share price fell by -45.72% over the past 1 year
What Is Apellis Pharmaceuticals 52-Week High & Low?
-
What Is Apellis Pharmaceuticals’s 52-Week High Share Price?
Apellis Pharmaceuticals has traded as high as $73.80 over the past 52 weeks -
What Is Apellis Pharmaceuticals’s 52-Week Low Share Price?
Apellis Pharmaceuticals has traded as low as $24.34 over the past 52 weeks
Apellis Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Apellis Pharmaceuticals?
-
How Much Debt Does Apellis Pharmaceuticals Have?
Total long term debt quarterly is $452.2M -
How Much Cash Does Apellis Pharmaceuticals Have?
Cash and short term investments quarterly total is $396.9M -
What Is Apellis Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.94
Is Apellis Pharmaceuticals Cash Flow Positive?
-
What Is APLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$205.1M -
What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $149.3M -
What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$379K
Apellis Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
APLS return on invested capital is -52.47% -
What Is Apellis Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -29.46% -
What Is APLS Return On Equity?
ROE is a measure of profitability and is -104.65%
Apellis Pharmaceuticals Earnings Date & Stock Price
-
What Is Apellis Pharmaceuticals's Stock Price Today?
A single share of APLS can be purchased today for 26.27 -
What Is Apellis Pharmaceuticals’s Stock Symbol?
Apellis Pharmaceuticals trades on the nasdaq under the ticker symbol: APLS -
When Is Apellis Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Apellis Pharmaceuticals is scheduled on February 27, 2025 -
When Is APLS's next ex-dividend date?
Apellis Pharmaceuticals's next ex-dividend date is November 19, 2024 -
How To Buy Apellis Pharmaceuticals Stock?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Apellis Pharmaceuticals Competitors
-
Who Are Apellis Pharmaceuticals's Competitors?
Below is a list of companies who compete with Apellis Pharmaceuticals or are related in some way:
Apellis Pharmaceuticals Dividend Yield
-
What Is APLS Dividend Yield?
Apellis Pharmaceuticals’s dividend yield currently is 0% -
What Is Apellis Pharmaceuticals’s Payout Ratio?
Apellis Pharmaceuticals’s payout ratio is 0% -
When Did Apellis Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 19, 2024 -
What Is Apellis Pharmaceuticals’s Dividend Per Share?
Apellis Pharmaceuticals pays a dividend of $0.00 per share
Apellis Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -71.42% |
Revenue: | 78.29% | -1.5% |
Analyst Recommendations
Buy Recommendations: | 11 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 0 |
Price Target: | 46.79 |
Upside from Last Price: | 78.11% |